Condition: Amyotrophic Lateral Sclerosis · ALS (Amyotrophic Lateral Sclerosis) · ALS With Frontotemporal Dementia (ALS/FTD) · Sponsor: ALS Therapy Development Institute
The goal of this natural history study is to learn more about the biological and clinical aspects of amyotrophic lateral sclerosis (ALS). This study's findings will help with drug discovery, biomarker discovery, and outcome measure validation. Adults living with ALS, other motor neuron diseases (MND), a known mutation related to ALS and healthy volunteers contribute prospective and retrospective data to this study remotely. The study is sponsored and conducted by the ALS Therapy Development Institute.
This description comes directly from the study's public registry record.
Alan S Premasiri, M.S. · 617-441-7200 · apremasiri@als.net
Beth Levine · 617-441-7200 · blevine@als.net
Always discuss trial participation with your own doctor first.
| ALS Therapy Development Institute | Watertown, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06885918